Morgan Stanley reports 8% stake in BioVie Inc.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC reported beneficial ownership of 605,472 shares of BioVie Inc. Class A common stock, representing 8.0% of the class as of June 30, 2026.

Rhea-AI Filing Summary

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC reported beneficial ownership of 605,472 shares of BioVie Inc. Class A common stock, representing 8.0% of the class as of June 30, 2026. Both entities list 0 shares with sole voting or dispositive power. They report 1 share with shared voting power and 605,472 shares with shared dispositive power, indicating these shares are controlled jointly within Morgan Stanley’s reporting units. The filing clarifies that it reflects only securities held by specified Morgan Stanley operating units and excludes positions disaggregated under SEC Release No. 34-39538.

Key Figures

Shares beneficially owned: 605,472 shares Percent of class: 8.0 % Sole voting power: 0 shares +4 more

7 metrics

Shares beneficially owned 605,472 shares BioVie Inc. Class A common stock reported by Morgan Stanley group

Percent of class 8.0 % Portion of BioVie Inc. Class A common stock beneficially owned

Sole voting power 0 shares Shares of BioVie Class A over which Morgan Stanley has sole voting power

Shared voting power 1 share BioVie Class A share over which Morgan Stanley has shared voting power

Shared dispositive power 605,472 shares BioVie Class A shares over which Morgan Stanley has shared dispositive power

CUSIP 09074F504 Identifier for BioVie Inc. Class A common stock

As-of date 06/30/2026 Date tied to reported ownership of BioVie Class A shares

Key Terms

beneficially owned, Sole Voting Power, Shared Dispositive Power, parent holding company, +1 more

5 terms

beneficially owned financial

"this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 0.00 6 | Shared Voting Power 1.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power financial

"8 | Shared Dispositive Power 605,472.00 9 605,472.00"

parent holding company financial

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

Joint Filing Agreement financial

"Exhibit Information EXHIBIT NO. EXHIBITS 99.1 Joint Filing Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in BioVie Inc. (BIVI) does Morgan Stanley report on this Schedule 13G?

Morgan Stanley and Morgan Stanley Smith Barney LLC report beneficial ownership of 605,472 shares of BioVie Inc. Class A common stock, representing 8.0% of the outstanding Class A shares as of June 30, 2026.

How much voting power does Morgan Stanley report over BIVI shares?

Morgan Stanley reports 0 shares with sole voting power and 1 share with shared voting power in BioVie Inc. Class A common stock, indicating essentially all reported holdings lack sole voting authority.

What dispositive power does Morgan Stanley have over its BIVI holdings?

Morgan Stanley and Morgan Stanley Smith Barney LLC report 0 shares with sole dispositive power and 605,472 shares with shared dispositive power, meaning decisions to sell or otherwise dispose of these BioVie shares are shared within the reporting group.

Which entities are the reporting persons on the BioVie Inc. (BIVI) Schedule 13G?

The reporting persons are Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC, both organized in Delaware and sharing a principal business address at 1585 Broadway, New York, NY 10036.

What class of BioVie Inc. securities is covered by this 13G filing for BIVI?

The filing covers Class A Common Stock of BioVie Inc., identified by CUSIP 09074F504, and details the beneficial ownership and voting/dispositive powers of Morgan Stanley and Morgan Stanley Smith Barney LLC.

Does the Morgan Stanley 13G for BIVI include all Morgan Stanley units?

No. It states it reflects securities beneficially owned by specified MS Reporting Units of Morgan Stanley and its affiliates and excludes operating units whose ownership is disaggregated under SEC Release No. 34-39538.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 05:13 PM Accepted by SEC EDGAR 08/07/2026 - 05:12 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

BIOVIE INC.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

09074F504

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 09074F504

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 605,472.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

605,472.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.0 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP Number(s): 09074F504

1

Names of Reporting Persons

Morgan Stanley Smith Barney LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 605,472.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

605,472.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.0 %

12

Type of Reporting Person (See Instructions)

BD, IA, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BIOVIE INC.
(b)	Address of issuer's principal executive offices: 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Smith Barney LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP Number(s): 09074F504
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 8.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	08/07/2026

Morgan Stanley Smith Barney LLC

Signature:	David Galasso
Name/Title:	Authorized Signatory, Morgan Stanley Smith Barney LLC
Date:	08/07/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).